Loading...
Loading...
Holder clone rankings through .
Among the 5 tracked institutional investors we monitor, ADRX (ADARX PHARMACEUTICALS INC) is held with a combined value of $192.42M across 9,649,863 shares. The largest holder is FMR LLC with a position worth $72.70M. 5 funds opened new positions in the most recent quarter.
Total Institutional Value
$192.42M
Total Shares Held
9,649,863
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $72.70M | 0.00% | New |
| 2 | PRICE T ROWE ASSOCIATES INC /MD/ | $57.72M | 0.01% | New |
| 3 | BlackRock, Inc. | $46.58M | 0.00% | New |
| 4 | MILLENNIUM MANAGEMENT LLC | $8.62M | 0.01% | New |
| 5 | CITADEL ADVISORS LLC | $6.80M | 0.00% | New |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of ADRX with a position worth $72.70M, representing 0.00% of their portfolio. In total, 5 institutional investors hold ADRX with a combined value of $192.42M.
In the most recent quarter, 5 funds opened a new position in ADRX.
Institutional investors hold $192.42M worth of ADRX stock across 5 positions. The largest institutional holder is FMR LLC with $72.70M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ADRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
None this quarter.
| — |
| 9.7% |
| 2026-11-13 |
| — | 10.5% | 2026-10-16 |
| 9,936,661 | 9.3% | 2026-10-05 |
| 14,913,764 | 14.0% | 2026-10-02 |
| — | 6.3% | 2026-10-01 |
SEC Schedule 13D (activist) and 13G (passive) filings for ADRX. Filed when an investor acquires 5%+ ownership.
Last Close
$12.82
2026-11-18
YTD
-33.7%
0% of 52-week range